Aniridia is a devastating ocular disease requiring intensive eye care, social and community support from birth and throughout an individual’s lifetime.

Recent News

© 2019 Aniridia-net.eu – University of Cologne – Webdesign by Effect Group Ltd.

Publications

Find out here ANIRIDIA-NET scientific publications, talks and posters, as well as guidelines for communicating action outcomes

Talks and Posters

Scientific Publications

PAX6 mutational status determines aniridia-associated keratopathy phenotype. https://www.aaojournal.org/article/S0161-6420(19)32101-3/abstract

Neil Lagali, Bogumil Wowra, Fabian Fries, Lorenz Latta, Kayed Moslemani, Tor Paaske Utheim, Edward Wylegala, Berthold Seitz, Barbara Käsmann-Kellner

Characteristics and Utility of Fundus Autofluorescence in Congenital Aniridia Using Scanning Laser Ophthalmoscopy. https://www.ncbi.nlm.nih.gov/pubmed/31574536

Landsend ECS, Pedersen HR, Utheim A, Rueegg CS, Baraas RC, Lagali N, Bragadóttir R, Moe MC, Utheim TP.

Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4120-4128. doi: https://doi.org/10.1167/iovs.19-26994

Acknowledging Cost Funding

All ANIRIDIA-NET members should acknowledge COST funding when communicating their work and results concerning the action. Please visit this website for guidelines and tips on communication and dissemination of COST action outcomes.
https://www.cost.eu/visual-identity/